AtriCure (ATRC) Rule 144 Notice: 5,000 Shares to Be Sold via Morgan Stanley
Rhea-AI Filing Summary
A person affiliated with AtriCure, Inc. (ATRC) intends to sell 5,000 shares of the company's common stock through Morgan Stanley Smith Barney LLC on the NASDAQ. The notice lists an approximate sale date of 08/19/2025 and an aggregate market value of $180,000 based on that sale. The shares were acquired on 08/19/2025 through a stock option exercise from the issuer and payment was made in cash. The filer reports no securities sold in the past three months for the account covered by this notice and includes the standard representation that the seller does not possess undisclosed material information about the issuer.
Positive
- Disclosure compliance: The filer provided required Rule 144 details including broker, quantity, acquisition method, and sale timing.
- No recent sales: The notice states there were no securities sold in the past three months for the account covered.
Negative
- Insider sale reported: The person for whose account the notice is filed intends to sell 5,000 common shares.
- Potential dilution context provided: The filing lists 49,701,415 shares outstanding, giving scale to the sale quantity.
Insights
TL;DR: Routine Rule 144 notice disclosing a small, open-market sale following a stock option exercise.
This Form 144 provides required public disclosure for an intended sale under Rule 144. It identifies the broker, the class and quantity of shares, the acquisition method as a stock option exercise, cash payment, and an approximate sale date. The statement that there were no sales in the prior three months and the seller's representation about material nonpublic information are standard compliance elements that allow market participants to assess adherence to resale conditions.
TL;DR: Small insider sale that is unlikely to affect company fundamentals given the share quantity disclosed.
The filing documents an intended sale of 5,000 common shares with an aggregate market value of $180,000 and shows total shares outstanding of 49,701,415. The shares were acquired via option exercise and are to be sold through a retail broker on NASDAQ. This disclosure is informative for monitoring insider activity but does not, by itself, convey operational or earnings information about the company.